Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reevaluation of antibiotic breakpoints.

I Phillips1

  • 1University of London, London, United Kingdom. iphillips@attglobal.net

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 24, 2001
PubMed
Summary

Antibiotic breakpoint variations stem from clinical practice and interpretation differences. Addressing these, especially with emerging pathogen resistance, requires careful consideration and education for microbiologists and clinicians.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying markers of cachexia and nutritional deficit on radical radiotherapy outcomes in lung and head and neck cancer.

Current opinion in supportive and palliative care·2026
Same author

Prehabilitation Reduces Hospital Admissions for Patients With Advanced Lung Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Comment on: Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where We are Today.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.

ESMO open·2022
Same author

In Response to: 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?' by Ostler et al. and 'Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No' by Macbeth and Hughes-Davies.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Screening two biodegradable polymers in enhanced efficiency fertiliser formulations reveals the need to prioritise performance goals.

Journal of environmental management·2021

Area of Science:

  • Microbiology
  • Pharmacology
  • Clinical Science

Background:

  • Antibiotic breakpoints vary due to differing clinical practices and interpretation of breakpoint-setting parameters.
  • Discrepancies in clinical practice are less frequent for newer antimicrobial agents.
  • Variations in parameter interpretation can potentially be resolved through consensus discussions.

Purpose of the Study:

  • To analyze the reasons behind variations in antibiotic breakpoint setting.
  • To discuss the challenges posed by evolving antimicrobial resistance in relation to breakpoints.
  • To recommend a cautious approach for breakpoint adjustments.

Main Methods:

  • Review of factors influencing antibiotic breakpoint determination.
  • Analysis of historical and current trends in antimicrobial resistance.
  • Examination of case studies involving resistance development (e.g., penicillin resistance in gonococci and pneumococci, fluoroquinolone resistance).

Main Results:

  • Differences in breakpoint setting primarily arise from interpretation variations and, less commonly, from clinical practice differences.
  • Emerging resistance in common pathogens, particularly gradual resistance, presents significant challenges.
  • Specific examples include the development of penicillin resistance in Neisseria gonorrhoeae and Streptococcus pneumoniae, and broad-spectrum fluoroquinolone resistance.

Conclusions:

  • Adjustments to antibiotic breakpoints necessitate careful deliberation.
  • Comprehensive education for diagnostic microbiologists and clinicians is crucial before implementing breakpoint changes.
  • A unified approach to breakpoint interpretation and resistance monitoring is essential for effective antimicrobial stewardship.

Related Experiment Videos